Publications by authors named "Seyma Atesoglu"

Claim this Profile
M
Morpholine-modified thiosemicarbazones and thiazolidin-4-ones against Alzheimer's key enzymes: From synthesis to inhibition.
Yeliz Demir, Halil Şenol, Orhan Uluçay, Şeyma Ateşoğlu, Feyzi Sinan Tokalı

Comput Biol Chem· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and cytotoxic evaluation of new thiosemicarbazone/thiazolidin-4-one derivatives on PC3 cells.
Feyzi Sinan Tokali, Halil Şenol, Şeyma Ateşoğlu, Pelin Tokalı, Fahri Akbaş

Future Med Chem· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of phenolic Mannich bases as α-glucosidase and aldose reductase inhibitors: In vitro and in silico approaches for managing diabetes mellitus and its complications.
Feyzi Sinan Tokalı, Yeliz Demir, Şeyma Ateşoğlu, Pelin Tokalı, Halil Şenol

Bioorg Med Chem· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Lung Cancer: Synthesis, Characterization, Enzyme Inhibition, and Antiproliferative Activity of 1H-Benzo[f]chromen-1-One-Thiosemicarbazones Supported by Molecular Docking.
Shahid Raza, Muhammad Islam, Furkan Çakır, Şeyma Ateşoğlu, Fahri Akbaş

Arch Pharm (Weinheim)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, antiproliferative activity targeting lung cancer and in silico studies of hydroxypiperidine substituted thiosemicarbazones.
Hina Aftab, Muhammad Islam, Halil Şenol, Zahra Batool, Şeyma Ateşoğlu

Sci Rep· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Quinazolin-4(3H)-One-Thiazolidine-2,4-Dione Hybrids as Dual Inhibitors of α-Glycosidase and Aldose Reductase: The Synthetic, In Vitro, and In Silico Approaches.
Feyzi Sinan Tokalı, Yeliz Demir, Pelin Tokalı, Şeyma Ateşoğlu, Halil Şenol

J Biochem Mol Toxicol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-Propyl-3-Aminoquinazoline-4(3H)-one Derivatives as Potential Androgen Receptor Inhibitors: Synthesis and Cytotoxicity Against PC3 Cell Line via In Vitro and In Silico Studies.
Halil Şenol, Furkan Çakır, Şeyma Ateşoğlu, Pelin Tokalı, Ayşe Merve Şenol

Arch Pharm (Weinheim)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Lung Cancer With Carvacrol-Triazole-Arylidene Hydrazide Hybrids: In Vitro and In Silico Cytotoxicity Assessments.
Furkan Çakır, Şeyma Ateşoğlu, Zeynep Ravza Müderrisoğlu, Firdevs Demirel, Fahri Akbaş

Chem Biodivers· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quinazolin-4(3H)-One-Based New Glitazones as Dual Inhibitors of α-Glucosidase and Aldose Reductase: Comprehensive Approaches for Managing Diabetes Mellitus and Its Complications.
Feyzi Sinan Tokalı, Yeliz Demir, Şeyma Ateşoğlu, Pelin Tokalı, Halil Şenol

Arch Pharm (Weinheim)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A series of quinazolin-4(3H)-one-morpholine hybrids as anti-lung-cancer agents: Synthesis, molecular docking, molecular dynamics, ADME prediction and biological activity studies.
Feyzi Sinan Tokalı, Halil Şenol, Şeyma Ateşoğlu, Fahri Akbaş

Chem Biol Drug Des· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis